Updated on 27 July 2026
AI/ML Technical Partner for Digital Health & Cluster 1 Consortia
Founder, HEEELP | PhD Candidate, Applied Informatics, University of Macedonia at ΗΕΕELP
Thessaloniki, Greece
About
HEEELP is a Greek ICT & R&D SME specialising in AI/ML systems, multi-agent architectures, and applied research, with technical expertise spanning medical imaging (including DICOM datasets), privacy-preserving AI, and secure distributed systems. The company is currently developing an AI-enabled mental health platform connecting psychologists and patients through a gamified therapy journey.
Our interest in this brokerage event centers on Cluster 1 Digital Health and AI topics, particularly Virtual Human Twins for integrated clinical decision support (HORIZON-HLTH-2027-03-TOOL-04) and the development of AI-based predictive biomarkers for chronic non-communicable diseases (HORIZON-HLTH-2027-02-TOOL-01-two-stage).
As a technology and R&D partner, HEEELP can contribute AI/ML algorithm development, system integration, and pilot implementation, particularly around predictive biomarker modelling and clinical decision-support pipelines.
We are looking to connect with clinical, biomedical, research, and industrial partners, as well as consortium coordinators, preparing Horizon Europe Cluster 1 proposals in these areas.
Topic
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Kai Gand
Grants Manager at Corsano Health
The Hague, Netherlands
Project cooperation
AI Benchmarking, Predictive Biomarkers and Multi-Omics in Health
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Raluca Abaseaca
Expert at Brussels Office of North East Romania Regional Development Agency
PIATRA NEAMT, Romania
Project cooperation
Fusing AI/ML with cheminformatics modelling into project concepts
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Evangelia-Mantelena Makri
Project Manager / Biomedical Scientist at Cloudpharm P.C
Athens, Greece